NEW YORK (
) hit a new 52-week high Tuesday as it is currently trading at $78.86, above its previous 52-week high of $78.58 with 395,851 shares traded as of 10:10 a.m. ET. Average volume has been 2.1 million shares over the past 30 days.
Allergan has a market cap of $23.9 billion and is part of the
industry. Shares are up 11.4% year to date as of the close of trading on Monday.
Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company has a P/E ratio of 23.5, above the S&P 500 P/E ratio of 16.7.
- Practice your AGN trading strategies and win cash in our stock game.
TheStreet Ratings rates Allergan as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full
52-week high stocks
or get investment ideas from our